This is a $27,844,029.94 cost-reimbursement contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to The McLean Hospital Corporation, a non-profit psychiatric teaching hospital affiliated with Harvard Medical School. The contract, which runs from September 1, 2019 to August 31, 2020 with options to extend through October 31, 2025, is for the NIH NeuroBioBank Brain and Tissue Repository. This repository collects, stores, and...
The National Institutes of Health (NIH) awarded a $25,599,848.14 cost-no-fee definitive contract to the University of Miami to establish the NIH Brain and Tissue Repository (NBTR) to acquire, receive, store, curate, preserve, and distribute central nervous system and related biological specimens for research on neurological, psychiatric, and neurodevelopmental disorders. The contract, which runs through October 31, 2025, does not have a set-aside designation. The University of Miami will be...
This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to the Greater Los Angeles Veterans Research And Education Foundation (GLAVREF), a non-profit organization. The contract, valued at $12,774,018.84, is for the NIH NEUROBIOBANK BRAIN AND TISSUE REPOSITORY and has a period of performance from September 1, 2019 to August 31, 2020, with a potential ultimate completion date of October 31, 2025. The...
This is a $18,636,390.59 definitive contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency of the U.S. government, to the University of Pittsburgh - Of The Commonwealth System of Higher Education. The contract is for the NEUROBIOBANK BRAIN AND TISSUE REPOSITORY, which will provide services to actively acquire, receive, store, characterize, catalog, preserve, and distribute human brain tissue and biospecimen samples to qualified investigators for research on...
This federal contract award, with an ID of 75N95019C00049, was made by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH), a civilian agency. The purpose of the $15,570,280.46 cost-no-fee definitive contract is to establish collection site(s) (i.e., the NIH Brain and Tissue Repository (NBTR)) to provide services that will actively acquire, receive, process, store, curate, preserve, and distribute central nervous system (CNS) and related...
This is a $6,885,849.71 cost-reimbursement contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the University of Maryland, Baltimore (UMB) to serve as the resource for the collection and evaluation of human tissue, cells, and bio-fluids from donors with an epidemiologic profile. The award supports medical research activities and does not have a set-aside designation. The contract has an ultimate completion date of September...
<p>The National Institute on Drug Abuse (NIDA), a civilian agency, has awarded a $1,433,356.00 Firm Fixed Price definitive contract to The Brain Donor Project, a non-profit organization, for NEUROBIOBANK (NBB) COMMUNICATIONS AND OUTREACH SERVICES. The contract has a period of performance through September 29, 2027 and was awarded on September 30, 2022. This contract is not set aside for any specific business type.</p>
This is a $2,036,522.37 definitive cost-reimbursement contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to The Johns Hopkins University to provide clinical services and resources for NIDA's Intramural Research Program (IRP) in Baltimore, Maryland. The contract has a base period of six months and nine six-month option periods, running through June 2025. The contract was awarded on July 1, 2020 and does not have a set-aside...
This is a $7,886,008 cost-type definitive contract awarded by the National Cancer Institute (NCI) to the University of Maryland, Baltimore (UMB) to serve as the "Resource for the Collection of Human Tissue, Cells, Biofluids and Epidemiologic Profiles from Donors." The contract will support NCI's Laboratory of Human Carcinogenesis research program and its studies on the molecular epidemiology and pathogenesis of lung, breast, liver, and pancreatic cancers. UMB, as the prime...
This is a federal contract award to the University of Maryland, Baltimore (UMB), a major public research university, for biomedical research and services. The $510,342.33 definitive contract was awarded on December 13, 1996 by the National Institutes of Health (NIH), a civilian agency, with a period of performance through December 31, 2005. The contract has a "Cost No Fee" pricing type, and was not set aside for any special business category. UMB, the prime contractor, provides a...
This is a $23,911,812.33 cost reimbursable contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) to operate the NIH NeuroBioBank and Tissue Repository. The contract does not have a set-aside designation.
The NeuroBioBank collects, stores, and distributes human brain tissue and other biospecimens to researchers studying neurological, psychiatric, and neurodevelopmental disorders. UMB, as the prime contractor, is responsible for acquiring specimens, maintaining an inventory, and facilitating tissue distribution to qualified investigators. The University System of Maryland is the parent organization of UMB.
UMB has also awarded a subcontract to The Johns Hopkins University to perform detailed microscopic analysis of brain tissue samples. This subcontract is valued at an undisclosed amount. The original pre-solicitation notice for this requirement was posted in October 2018, seeking providers with the capability to acquire and manage a repository of up to 1,000 unique human donors over a 5-year period.